martes, 21 de noviembre de 2023

ABBV-552 for Early-Stage Alzheimer's Disease + CT1812 for Early-Stage Alzheimer's Disease + Therapeutic Plasma Exchange To Reduce Blood Biomarkers Linked to Alzheimer's Disease + Volunteers needed for studies to advance dementia research

ABBV-552 for Early-Stage Alzheimer's Disease Volunteers needed for studies to advance dementia research https://www.alzheimers.gov/clinical-trials/abbv-552-early-stage-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231120 CT1812 for Early-Stage Alzheimer's Disease Volunteers needed for studies to advance dementia research https://www.alzheimers.gov/clinical-trials/ct1812-early-stage-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231120 Therapeutic Plasma Exchange To Reduce Blood Biomarkers Linked to Alzheimer's Disease Volunteers needed for studies to advance dementia research https://www.alzheimers.gov/clinical-trials/therapeutic-plasma-exchange-reduce-blood-biomarkers-linked-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231120

No hay comentarios:

Publicar un comentario